NASDAQ:AKTX

Akari Therapeutics Stock Predictions

etoro logo Buy AKTX
*Your capital is at risk
$14.99
+0.355 (+2.43%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

AKTX Prediction Chart

AKTX Predictions History

Latest community submissions for AKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Jun 22, 2021 $1.66 -99.88% $1.70 V 97.65% 0
Jun 22, 2021 Bearish $1.70 V 0
Jun 22, 2021 $1.77 -99.87% $1.70 V 95.88% 1
Jun 5, 2020 Bullish $2.47 X 1
Jun 5, 2020 $2.30 -99.88% $2.47 V 93.12% 0
Ramzi Amer Ramzi Amer @RamziAmer.162796
Jun 5, 2020 $2.30 -99.88% $2.47 V 93.12% 0
Alan Stevenson Alan Stevenson @AlanStevenson.160541
Jun 5, 2020 $2.49 -99.87% $2.47 X 99.19% 3
Apr 29, 2019 $3.34 -99.88% $3.44 V 97.09% 0
Apr 23, 2019 $3.54 -99.89% $3.88 X 91.24% 0
Mar 20, 2019 $5.30 -99.84% $4.10 X 70.70% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for AKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT AKARI THERAPEUTICS PLC
Akari Therapeutics
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE